23rd week of 2019 patent applcation highlights part 11 |
Patent application number | Title | Published |
20190167760 | POLYPEPTIDES BINDING TO HUMAN COMPLEMENT C5 | 2019-06-06 |
20190167761 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING STRESS-RELATED DISEASE, INCLUDING DISC1 PROTEIN OR GENE ENCODING THE SAME | 2019-06-06 |
20190167762 | EFFICIENT SYSTEMIC TREATMENT OF DYSTROPHIC MUSCLE PATHOLOGIES | 2019-06-06 |
20190167763 | TOPICAL PHARMACEUTICAL COMPOSITION FOR PROMOTING HAIR GROWTH AND/OR REDUCING HAIR LOSS | 2019-06-06 |
20190167764 | METHOD AND APPARATUS FOR INTERFACE CONTROL WITH PROMPT AND FEEDBACK | 2019-06-06 |
20190167765 | HUMAN SERUM ALBUMIN-BASED TOPICAL OINTMENT FOR TREATMENT OF ACNE, PSORIASIS, EGFR-INDUCED TOXICITY, PREMATURE SKIN AGING AND OTHER SKIN CONDITIONS | 2019-06-06 |
20190167766 | Formulations for Nutritional Support in Subjects in Need Thereof | 2019-06-06 |
20190167767 | THERAPEUTIC COMBINATIONS TO TREAT RED BLOOD CELL DISORDERS | 2019-06-06 |
20190167768 | COMPOSITIONS AND METHODS FOR TREATING NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID) ASSOCIATED COAGULOPATHY, THROMBOCYTOPENIA, GLANZMANN'S THROMBASTHENIA, AND/OR THROMBOSIS | 2019-06-06 |
20190167769 | FEED ADDITIVE COMPOSITION | 2019-06-06 |
20190167770 | METHOD AND COMPOSITION FOR TREATING ARGINASE 1 DEFICIENCY | 2019-06-06 |
20190167771 | CONTROL ANGIOGENESIS BY REGULATING PHOSPHORYLATION OF SERYL-tRNA SYNTHETASE (SerRS) | 2019-06-06 |
20190167772 | Sea Lice Vaccine | 2019-06-06 |
20190167773 | METHODS AND MATERIALS FOR TREATING CANCER | 2019-06-06 |
20190167774 | TARGETING DNA VACCINES TO B CELLS AS PRIMARY ANTIGEN PRESENTING CELLS | 2019-06-06 |
20190167775 | METHODS AND COMPOSITIONS FOR TREATING CANCER | 2019-06-06 |
20190167776 | CAMKK2 INHIBITOR COMPOSITIONS AND METHODS OF USING THE SAME | 2019-06-06 |
20190167777 | ADJUVANT COMPOSITIONS AND RELATED METHODS | 2019-06-06 |
20190167778 | IMMUNOMODULATORY MINICELLS AND METHODS OF USE | 2019-06-06 |
20190167779 | Synthetic Antigen Constructs Against Campylobacter Jejuni | 2019-06-06 |
20190167780 | INFLUENZA VIRUS VACCINES | 2019-06-06 |
20190167781 | RECOMBINANT INFLUENZA VIRUSES WITH STABILIZED HA FOR REPLICATION IN EGGS | 2019-06-06 |
20190167782 | VACCINATION IN NEWBORNS AND INFANTS | 2019-06-06 |
20190167783 | VACCINE | 2019-06-06 |
20190167784 | RECOMBINANT VIRUS WITH DIMINISHED LATENCY AND METHODS OF USING SAME | 2019-06-06 |
20190167785 | METHODS OF ORAL IMMUNOTHERAPY | 2019-06-06 |
20190167786 | EMULSIONS WITH FREE AQUEOUS-PHASE SURFACTANT FOR ADJUVANTING SPLIT INFLUENZA VACCINES | 2019-06-06 |
20190167787 | Methods and Compositions for Inhibiting Akt3 | 2019-06-06 |
20190167788 | Composition and Method for Treating Cancer | 2019-06-06 |
20190167789 | IMMUNOTHERAPY TREATMENTS AND COMPOSITIONS | 2019-06-06 |
20190167790 | ABT-165 IN COMBINATION WITH FOLINIC ACID, 5-FLUOROURACIL, AND IRINOTECAN FOR THE TREATMENT OF CANCERS | 2019-06-06 |
20190167791 | IMMUNOTHERAPEUTIC USES OF EX VIVO GENERATED FOXP3+ REGULATORY T CELLS | 2019-06-06 |
20190167792 | Anaerobic Blood Storage and Pathogen Inactivation Method | 2019-06-06 |
20190167793 | NEAR-IR LIGHT-CLEAVABLE CONJUGATES AND CONJUGATE PRECURSORS | 2019-06-06 |
20190167794 | ATROPISOMERS OF HALOGENATED TETRAPHENYLBACTERIOCHLORINS AND CHLORINS AND THEIR USE IN PHOTODYNAMIC THERAPY | 2019-06-06 |
20190167795 | CONJUGATED LIPOMERS AND USES THEREOF | 2019-06-06 |
20190167796 | METHODS OF TREATING OR PREVENTING STENT THROMBOSIS | 2019-06-06 |
20190167797 | STABILIZED FACTOR IX FORMULATIONS CONTAINING TREHALOSE | 2019-06-06 |
20190167798 | MEMBRANE FOR STICKING TO LIVING ORGANISM, AND METHOD FOR PRODUCING SAME | 2019-06-06 |
20190167799 | ETHER TYPE GLYCEROPHOSPHOLIPID-CONTAINING COMPOSITION AND METHOD FOR PRODUCING THE SAME | 2019-06-06 |
20190167800 | NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS | 2019-06-06 |
20190167801 | Injectable, Non-Aqueous Suspension with High Concentration of Therapeutic Agent | 2019-06-06 |
20190167802 | SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID | 2019-06-06 |
20190167803 | TLR9 TARGETED CYTOTOXIC AGENTS | 2019-06-06 |
20190167804 | GLUCOCORTICOID RECEPTOR AGONIST AND IMMUNOCONJUGATES THEREOF | 2019-06-06 |
20190167805 | Immunoconjugates with an Intracellularly-Cleavable Linkage | 2019-06-06 |
20190167806 | DRUG CONJUGATES WITH SELF-STABILIZING LINKERS HAVING IMPROVED PHYSIOCHEMICAL PROPERTIES | 2019-06-06 |
20190167807 | Adipose Tissue-Targeting Polypeptide-Verbascoside-Nanogold Particle Derivative, Preparation Method and Application Thereof | 2019-06-06 |
20190167808 | METHODS OF TREATING PHENYLKETONURIA WITH MRNA ENCODING PHENYLALANINE HYDROXYLASE (PAH) | 2019-06-06 |
20190167809 | METHODS OF TREATING A SUBJECT WITH mRNA ENCODING COAGULATION FACTOR VIII (F8) | 2019-06-06 |
20190167810 | EXOSOMES COMPRISING THERAPEUTIC POLYPEPTIDES | 2019-06-06 |
20190167811 | LIPID COMPOSITIONS AND THEIR USES FOR INTRATUMORAL POLYNUCLEOTIDE DELIVERY | 2019-06-06 |
20190167812 | NUCLEIC ACID CONDENSING PEPTIDE, NUCLEIC ACID CONDENSING PEPTIDE SET, NUCLEIC ACID DELIVERY CARRIER, NUCLEIC ACID DELIVERY METHOD, CELL PRODUCTION METHOD, CELL DETECTION METHOD AND KIT | 2019-06-06 |
20190167813 | COMPOSITIONS AND METHODS OF REPLICATION DEFICIENT ADENOVIRAL VECTORS FOR VACCINE APPLICATIONS | 2019-06-06 |
20190167814 | Treatment And/Or Prevention Of DNA-Triplet Repeat Diseases Or Disorders | 2019-06-06 |
20190167815 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF RARE DISEASES | 2019-06-06 |
20190167816 | METHODS FOR PREVENTING OR TREATING FIBROTIC DISEASES | 2019-06-06 |
20190167817 | TREATING METASTATIC CANCER AND MODEL SYSTEMS FOR METASTATIC DISEASE | 2019-06-06 |
20190167818 | FLUORESCENT SOLID LIPID NANOPARTICLES COMPOSITION AND PREPARATION THEREOF | 2019-06-06 |
20190167819 | CONTRAST AGENTS | 2019-06-06 |
20190167820 | NOVEL ARYL ETHENE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT | 2019-06-06 |
20190167821 | PROBES FOR IMAGING HUNTINGTIN PROTEIN | 2019-06-06 |
20190167822 | NON-IODINATED RADIOLABELED RADIOPAQUE MICROBEADS WITH MRI CONTRAST FOR RADIOEMBOLIZATION | 2019-06-06 |
20190167823 | METHOD FOR TREATING SOLUTION CONTAMINATED WITH PORCINE CIRCOVIRUSES | 2019-06-06 |
20190167824 | STERILIZATION TRAY | 2019-06-06 |
20190167825 | Devices Using Flexible Light Emitting Layer for Creating Disinfecting Illuminated Surface, and Related Method | 2019-06-06 |
20190167826 | Cover with Disinfecting Illuminated Surface | 2019-06-06 |
20190167827 | UV Disinfection Device and Method | 2019-06-06 |
20190167828 | SYSTEMS, METHODS, AND DEVICES FOR OZONE SANITIZATION OF CONTINUOUS POSITIVE AIRWAY PRESSURE DEVICES | 2019-06-06 |
20190167829 | INTEGRATED FOGGING SYSTEM PROVIDING ATOMIZED SOLUTION TO AN ENCLOSED TREATMENT AREA AND RELATED METHODS | 2019-06-06 |
20190167830 | AUTOCLAVE WITH AUTONOMOUS INTERNAL STERILISING CHAMBERS FOR STERILISING SANITARY WASTE AND MEDICAL INSTRUMENTS | 2019-06-06 |
20190167831 | SCENT ENHANCED TRAJECTORY | 2019-06-06 |
20190167832 | Purified Hydrogen Peroxide Gas Generation Methods and Devices | 2019-06-06 |
20190167833 | AIR PURIFILER | 2019-06-06 |
20190167834 | VACUUM MEMBRANE THERMOFORMED POLY-4-HYDROXYBUTYRATE MEDICAL IMPLANTS | 2019-06-06 |
20190167835 | ANTIOXIDANT AND ANTIMICROBIAL WOUND DRESSING MATERIALS | 2019-06-06 |
20190167836 | Super Absorbent Polymer | 2019-06-06 |
20190167837 | READY-TO-USE, HYDROPHILIC, SELF-DISPERSIVE, FRAGMENTABLE AND BIODEGRADABLE POROUS SPONGE MATRIX AND A METHOD OF MANUFACTURING THEREOF | 2019-06-06 |
20190167838 | PHOSPHORYLATED POLY (ESTER-UREA) BASED DEGRADABLE BONE ADHESIVES | 2019-06-06 |
20190167839 | ABSORBABLE IN SITU GEL-FORMING SYSTEM, METHOD OF MAKING AND USE THEREOF | 2019-06-06 |
20190167840 | HEMOSTATIC FLOWABLE | 2019-06-06 |
20190167841 | METHOD FOR PRODUCING CALCIUM PHOSPHATE MOLDED ARTICLE, CALCIUM PHOSPHATE MOLDED ARTICLE, AND MATERIAL FOR TRANSPLANTATION | 2019-06-06 |
20190167842 | ALIGNED FIBER AND METHOD OF USE THEREOF | 2019-06-06 |
20190167843 | NERVE GUIDANCE CONDUITS, METHODS OF PRODUCTION AND USES THEREOF | 2019-06-06 |
20190167844 | BIODEGRADABLE SINGLE-PHASE COHESIVE HYDROGELS | 2019-06-06 |
20190167845 | IN SITU TISSUE ENGINEERING | 2019-06-06 |
20190167846 | MESENCHYMAL STEM CELL-MEDIATED FUNCTIONAL TOOTH REGENERATION | 2019-06-06 |
20190167847 | MAGNETICALLY ACTUATED ARTICULAR CARTILAGE REGENERATION SYSTEM | 2019-06-06 |
20190167848 | SELENIUM-DOPED HYDROXYAPATITE AND PREPARATION METHOD THEREOF | 2019-06-06 |
20190167849 | WETTING AGENT FORMULATION | 2019-06-06 |
20190167850 | HYDROGEL PATCH | 2019-06-06 |
20190167851 | ORTHOPEDIC IMPLANT FOR SUSTAINED DRUG RELEASE | 2019-06-06 |
20190167852 | SYSTEMS AND METHODS OF RADIOPROTECTION OF ALLOGRAFTS | 2019-06-06 |
20190167853 | MOLDABLE BONE GRAFT COMPOSITIONS | 2019-06-06 |
20190167854 | DRUG COATED BALLOON CATHETERS FOR NONVASCULAR STRICTURES | 2019-06-06 |
20190167855 | ANTIMICROBIAL COATING FORMING KINK RESISTANT FEATURE ON A VASCULAR ACCESS DEVICE | 2019-06-06 |
20190167856 | SYSTEMS AND METHODS FOR FORMING MATERIALS IN SITU WITHIN A MEDICAL DEVICE | 2019-06-06 |
20190167857 | BIOFOULING RESISTANT COATINGS AND METHODS OF MAKING AND USING THE SAME | 2019-06-06 |
20190167858 | SUSTAINED RELEASE INTRAOCULAR IMPLANTS AND METHODS FOR TREATING OCULAR VASCULOPATHIES | 2019-06-06 |
20190167859 | IMPLANTABLE MEDICAL PRODUCTS, A PROCESS FOR THE PREPARATION THEREOF, AND USE THEREOF | 2019-06-06 |